Is Edwards Lifesciences Corporation (EW) A Good Stock To Buy Now? [Yahoo! Finance]
Edwards Lifesciences Corporation (EW)
Last edwards lifesciences corporation earnings: 4/23 04:15 pm
Check Earnings Report
US:NYSE Investor Relations:
ir.edwards.com
Company Research
Source: Yahoo! Finance
In this article, we will summarize the bulls' thesis on EW. Edwards Lifesciences Corporation's share was trading at $83.92 as of March 16th. EW's trailing and forward P/E were 46.17 and 28.49 respectively according to Yahoo Finance. Sergey Nivens/Shutterstock.com Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States and internationally. EW has completed its transition into a pure-play structural heart disease leader, sharpening its focus on high-growth, high-margin segments following the divestiture of its Critical Care business to Becton, Dickinson and Company for $4.2 billion in cash. Read More: 15 AI Stocks That Are Quietly Making Investors Rich Read More: Undervalued AI Stock Poised For Massive Gains: 10000% Upside Potential This strategic move, while removing roughly 20% of its 2023 EBITDA base, has been effectively offset by the rapid expansion of its Transcatheter Mitral and Tricuspid Therapi
Show less
Read more
Impact Snapshot
Event Time:
EW
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EW alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EW alerts
High impacting Edwards Lifesciences Corporation news events
Weekly update
A roundup of the hottest topics
EW
News
- Two Year Data on Edwards Lifesciences' EVOQUE System Continue to Demonstrate Significant and Sustained Patient Benefits [Yahoo! Finance]Yahoo! Finance
- Two Year Data on Edwards Lifesciences’ EVOQUE System Continue to Demonstrate Significant and Sustained Patient BenefitsBusiness Wire
- Philips wins FDA clearance for imaging device developed with Edwards [Yahoo! Finance]Yahoo! Finance
- 13 U.S. health care stocks to consider in uncertain markets [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- Field Medical Names Mark A. Turco, MD, as Chief Executive Officer [Yahoo! Finance]Yahoo! Finance
EW
Earnings
- 2/10/26 - Miss
EW
Sec Filings
- 3/26/26 - Form SCHEDULE
- 3/26/26 - Form ARS
- 3/26/26 - Form DEFA14A
- EW's page on the SEC website